Mental Health Therapy Apps 2023 vs 2026 Will Market Grow

By 2026 the global mental health apps market is projected to hit $9.6 billion, up from $7.5 billion in 2023. Look, the surge reflects heightened anxiety after the pandemic and smartphones reaching more Australians than ever before. In my experience around the country I’ve seen this play out in clinics that now hand patients a QR code to start therapy.

By 2026, the mental health app development market is projected to soar to a multi-billion-dollar industry - putting untapped potential right in your roadmap.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Global Landscape: Mental Health Therapy Apps Reach New Heights

In the first year of the COVID-19 pandemic WHO data showed a 25% jump in anxiety and depression rates worldwide, creating a tidal wave of demand for digital solutions. I spoke to a Sydney-based counsellor who told me that half of her new clients now request an app as part of their treatment plan. That on-the-ground reality mirrors the numbers: by the end of 2024, 27% of North America’s population were using mental health therapy apps, a figure that signals similar uptake across Australia and Europe.

According to a market report on appinventiv.com, the global mental health apps market was valued at $7.48 billion in 2024 - an 18% rise from 2023. The growth is largely driven by unmet anxiety needs; users are looking for anytime-anywhere coping tools that traditional services can’t always provide. The same report notes that smartphone penetration in developed markets now exceeds 80%, meaning the platform is already in the hands of most potential users.

From my nine years covering health tech, I’ve learned that adoption is rarely linear. Early adopters - often younger professionals in Melbourne’s CBD - jump on the bandwagon, and the ripple effect reaches older demographics through family recommendation. The result is a cross-generational push that pushes the market beyond the tech-savvy niche.

• COVID-19 impact: 25% rise in anxiety and depression (WHO)
• North America usage: 27% of population in 2024
• Global market value 2024: $7.48 billion
• Smartphone penetration: >80% in developed markets (GSMA)

Key Takeaways

• COVID-19 drove a 25% rise in anxiety globally.
• 27% of North Americans used therapy apps by 2024.
• Market grew 18% to $7.48 billion in 2024.
• Smartphone penetration exceeds 80% in wealthy nations.
• Australian clinicians now routinely prescribe apps.

Market Size Explosion: From $7.5B to $40.9B by 2035

The trajectory is nothing short of spectacular. Forecasts from Substack’s February Funding Intelligence predict the market will reach $17.52 billion by 2030 and blow past $40 billion by 2035. That translates to a compounded annual growth rate of roughly 14.6% from 2025 to 2030 - a pace that would make even the mining sector blush.

Between 2025 and 2026 alone, the market is set to climb from $8.2 billion to $9.6 billion, a 17.4% CAGR. I’ve chatted with a startup founder in Brisbane who says their valuation doubled after securing a Series A round, largely because investors are chasing the “inflation-resistant” promise of digital health services.

To put those numbers in perspective, here’s a quick snapshot:

Those figures are more than just numbers on a slide - they shape hiring plans, R&D budgets, and even university curricula. In my reporting, I’ve seen universities launch specialised Masters programmes in digital therapeutics to feed the talent pipeline.

1. 2023 baseline: $7.5 bn - the market was still niche.
2. 2024 dip: Slight dip to $7.48 bn as investors re-evaluated post-pandemic demand.
3. 2025-2026 surge: 17.4% CAGR fuels new entrants.
4. 2030 milestone: $17.52 bn - a clear inflection point.
5. 2035 horizon: $40.9 bn - the sector rivals traditional pharma.

Growth Catalysts: Pandemic Trauma Meets Digital Therapeutics

What’s powering this explosion? The lingering trauma of the pandemic is a major driver. WHO data highlighted a 25% increase in anxiety and depression during the first year of COVID-19, and that unmet need has not vanished. Instead, it’s migrated onto smartphones. I’ve spoken to a Perth emergency department head who says his staff now use an AI-enabled app to de-stress after a shift - a practice that would have been unheard of a decade ago.

Mobile internet penetration is climbing about 5% year-over-year, according to the GSMA Mobile Economy Report 2023. In Australia, 91% of households now have a reliable broadband connection, meaning users can stream guided meditations or CBT modules without a hiccup.

China offers a glimpse of the scale: projections suggest that by 2030, 80% of people with depression will actively seek treatment, many through digital platforms. That translates to millions of new users and a ripple effect for global app developers seeking to localise content.

• 25% rise in anxiety globally (WHO)
• 5% annual growth in mobile internet penetration (GSMA)
• 91% Australian broadband coverage (Australian Communications and Media Authority)
• 80% of Chinese depressed patients projected to seek help by 2030 (industry forecasts)
• App-based CBT shows 30% faster symptom reduction in pilot trials (University of Sydney study)

All these forces converge to create a market that feels both urgent and sustainable. Investors are not just chasing hype; they see a social return on investment that aligns with government mental-health strategies.

Digital Mental Health Solutions: Chatbots and AI Take Center Stage

Artificial intelligence is no longer a side-show. Chatbot-driven platforms like Woebot and Wysa are responsible for roughly 70% of user engagement in 2025, according to appinventiv.com. Users appreciate the anonymity and instant feedback, especially in regional Australia where face-to-face services can be sparse.

Bloom’s AI-mindfulness platform, which integrates biometric feedback from smartwatches, has reportedly cut first-responder response times by 30% in pilot programs across Queensland. The technology analyses heart-rate variability to gauge stress levels and then nudges the user with a micro-meditation.

Governments are stepping in, too. The Australian Digital Health Agency announced this year that it will certify AI therapeutic algorithms that meet rigorous safety standards, opening a procurement pipeline for vendors seeking public-sector contracts.

• Woebot & Wysa: 70% engagement
• Bloom’s biometric AI: 30% faster response (Queensland pilot)
• Government certification: New procurement avenues (Australian Digital Health Agency)
• Regional uptake: 45% of users in outback NSW report improved sleep
• Data security: 99.9% encryption compliance (Australian Privacy Principles)

From my newsroom desk, I’ve watched these tools move from novelty to core components of care pathways. When a therapist I interviewed in Adelaide said, “I now assign a chatbot as homework before our sessions,” it underscored how AI is becoming a bridge rather than a replacement.

Psychotherapy Mobile Apps: Bridges Between Patients and Care

Traditional therapy still matters, but mobile apps are becoming the connective tissue that holds the whole system together. Headspace, for instance, rolled out twice-daily guided modules in 2024 and saw adherence jump 48% compared with on-site therapy, according to a UX study published in the Journal of Medical Internet Research.

Clinical validation matters. A 2024 survey of 1,200 clinicians across Australia found that when a mobile therapy platform scored above 85% on acceptance metrics, patient trust rose by up to 60%. That trust translates into better outcomes and lower dropout rates.

Cost is another compelling factor. U.S. physicians reported a 22% reduction in per-patient expenses after shifting 30% of their caseload to structured mobile therapy, while maintaining the same quality metrics. In Australian private practice, that could mean hundreds of dollars saved per client, a boon for both providers and patients navigating out-of-pocket costs.

1. Headspace adherence: 48% increase with twice-daily modules.
2. Clinician acceptance: >85% score lifts trust by 60%.
3. Cost reduction: 22% lower expenses in US study.
4. Patient retention: Mobile-first models keep 35% more users engaged long-term.
5. Outcome parity: Symptom improvement matches in-person CBT in 78% of trials.

Frequently Asked Questions

Q: How fast is the mental health app market expected to grow?

A: Forecasts show the market will rise from $7.5 billion in 2023 to $9.6 billion in 2026, a 17.4% compound annual growth rate, and could exceed $40 billion by 2035.

Q: What drove the surge in app usage after the pandemic?

A: WHO reported a 25% jump in anxiety and depression during the first pandemic year, creating urgent demand for anytime-anywhere digital therapy solutions.

Q: Are AI-driven chatbots effective?

A: Yes. Chatbot platforms like Woebot and Wysa generate roughly 70% of user engagement and have been linked to faster stress reduction in pilot studies.

Q: Do mental health apps save money for patients?

A: In the United States, shifting 30% of therapy to mobile platforms cut per-patient costs by 22%; similar savings are expected in Australia as providers adopt hybrid models.

Q: What’s the outlook for government involvement?

A: The Australian Digital Health Agency is now certifying AI therapeutic algorithms, opening public-sector contracts and legitimising digital tools as part of national mental-health strategies.